InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the ” Neurogenomics Market– (By Offering (Next-Generation Sequencing (NGS) systems, kits & reagents; DNA extraction and amplification kits & reagents; library preparation and target enrichment kits & reagents; quality control kits & reagents; other NGS kits & reagents; Polymerase Chain Reaction (PCR) systems, kits & reagents; microarrays; readers & scanners; DNA/RNA, protein, and tissue microarray kits & reagents; software & services), By Application (Variant discovery, research applications, target identification, transcription factor binding analysis, functional studies, clinical applications), By End-user (Pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”
According to the latest research by InsightAce Analytic, the Neurogenomics Market is valued at USD 1.7 Bn in 2024, and it is expected to reach USD 7.3 Bn by the year 2034, with a CAGR of 16.2% during the forecast period of 2025-2034.
Check this Report Brochure : https://www.insightaceanalytic.com/request-sample/3012
Neurogenomics is an interdisciplinary field that merges genomics with neuroscience to explore the influence of genetic factors on the development, function, and pathology of the nervous system. It focuses on analyzing how variations in an individual’s genetic code affect brain structure, cognitive function, behavior, and the onset of neurological disorders. The neurogenomics market is experiencing steady growth, driven by the increasing prevalence of neurological diseases, declining costs associated with genomic sequencing, and the rising adoption of advanced sequencing technologies in precision medicine and diagnostics. Furthermore, heightened awareness of neurological conditions, expanding healthcare infrastructure in emerging markets, and the growing application of targeted therapeutic approaches are expected to offer significant growth opportunities for industry stakeholders.
List of Prominent Players in the Neurogenomics Market:
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche Ltd.
- Danaher Corporation
- Qiagen N. V.
- Agilent Technologies Inc.
- Oxford Nanopore Technologies Plc.
- Revvity Inc.
- Pacific Biosciences of California Inc.
- MGI Tech Co. Ltd.
Market Dynamics
Drivers:
The neurogenomics market is witnessing robust growth, primarily driven by the rising prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis. The growing global aging population significantly contributes to the increased incidence of these neurodegenerative conditions, thereby heightening the demand for accurate diagnostic tools and targeted therapeutic approaches. As genetic factors play a critical role in the onset and progression of many neurological diseases, neurogenomics is emerging as a pivotal solution for early detection and personalized treatment. Both healthcare providers and patients are increasingly leveraging genomic insights to better understand disease mechanisms and develop tailored intervention strategies.
Challenges:
Despite technological advancements, the high cost associated with genome sequencing and neurogenomic data analysis remains a key barrier to broader adoption. Although next-generation sequencing (NGS) technologies have become more cost-effective over time, comprehensive neurogenomic analyses—especially those targeting complex neurological conditions—still require significant financial investment. Expenses related to data processing, computational infrastructure, and skilled personnel further elevate overall costs. These challenges are particularly pronounced in low- and middle-income countries, where limited healthcare budgets restrict access to advanced genomic diagnostics and therapies, ultimately preventing many patients from benefiting from these innovations.
Regional Trends:
North America is expected to maintain a dominant position in the neurogenomics market due to substantial investment in research and development across the biotechnology and pharmaceutical sectors, the presence of leading genomic solution providers, favorable reimbursement policies, and a high prevalence of neurological diseases. Additionally, supportive government initiatives promoting genomics research are further strengthening regional market growth. Meanwhile, the Asia-Pacific region is projected to experience the highest growth rate over the forecast period, driven by increasing patient populations, rising healthcare expenditure, and growing public awareness of genomic medicine. Government-backed programs encouraging precision medicine, along with advancements in sequencing technologies, are accelerating the integration of neurogenomics into healthcare practices across the region.
Recent Development:
- In Feb 2022, The Montreal Neurological Institute-Hospital at McGill University (The Neuro) has announced a new research collaboration with Illumina, Takeda Development Center Americas, Inc., and Roche. The collaboration, propelled by Illumina’s whole genome sequencing technology, will establish a robust drug development platform for neurological illnesses, including Parkinson’s disease and REM sleep behavior disorders.
Segmentation of Neurogenomics Market-
By Offering-
- Next-Generation Sequencing (NGS)
- Systems
- Kits & Reagents
- DNA Extraction and Amplification Kits & Reagents
- Library Preparation and Target Enrichment Kits & Regents
- Quality Control Kits & Reagents
- Other NGS Kits & Reagents
- Polymerase Chain Reaction (PCR)
- Systems
- Kits & Reagents
- Microarray+
- Readers & Scanners
- DNA and RNA Microarray Kits & Reagents
- Protein Microarray Kits & Reagents
- Tissue Microarray Kits & Reagents
- Software & Services
By Application-
- Variant Discovery
- Research Applications
- Target Identification
- Transcription Factor Binding Analysis
- Functional Studies
- Clinical Applications
By End-user-
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
